An area-optimized N-bit multiplication technique using N/2-bit multiplication algorithm

A unique design for an optimized N-bit multiplier is proposed and implemented which utilizes a modified divide-and-conquer technique. The conventional technique requires four N/2-bit multipliers to perform N-bit multiplication, whereas the proposed design uses only one multiplier module in hardware to perform the functionality of four modules. It uses Dadda algorithm in its multiplier module. It has been implemented using Verilog HDL, and a good accuracy of results was observed in simulations which effectively verify its functionality. Design was also synthesized on various FPGAs including Spartan 3E, Virtex-5 and Virtex-7. Performance summary, after place and route, showed that the proposed approach significantly reduces hardware utilization. Furthermore, the proposed design is almost 75% more efficient in terms of resources utilization and operating frequency as compared to the conventional design

Radiation monitor RADMON aboard Aalto-1 CubeSat : First results

The Radiation Monitor (RADMON) on-board Aalto-1 CubeSat is an energetic particle detector that fulfills the requirements of small size, low power consumption and low budget. Aalto-1 was launched on 23 June 2017 to a sun-synchronous polar orbit with 97.4° inclination and an average altitude of somewhat above 500 km. RADMON has been measuring integral particle intensities from October 2017 to May 2018 with electron energies starting at low-MeV and protons from 10 MeV upwards. In this paper, we present first electron and proton intensity maps obtained over the mission period. In addition, the response of RADMON measurements to magnetospheric dynamics are analyzed, and the electron observations are compared with corresponding measurements by the PROBA-V/EPT mission. Finally, we describe the RADMON data set, which is made publicly available.The Radiation Monitor (RADMON) on-board Aalto-1 CubeSat is an energetic particle detector that fulfills the requirements of small size, low power consumption and low budget. Aalto-1 was launched on 23 June 2017 to a sun-synchronous polar orbit with 97.4 degrees inclination and an average altitude of somewhat above 500 km. RADMON has been measuring integral particle intensities from October 2017 to May 2018 with electron energies starting at low-MeV and protons from 10 MeV upwards. In this paper, we present first electron and proton intensity maps obtained over the mission period. In addition, the response of RADMON measurements to magnetospheric dynamics are analyzed, and the electron observations are compared with corresponding measurements by the PROBA-V/EPT mission. Finally, we describe the RADMON data set, which is made publicly available. (C) 2019 COSPAR. Published by Elsevier Ltd. All rights reserved.Peer reviewe

Radiation monitor RADMON aboard Aalto-1 CubeSat: First results

The Radiation Monitor (RADMON) on-board Aalto-1 CubeSat is an energetic particle detector that fulfills the requirements of small size, low power consumption and low budget. Aalto-1 was launched on 23 June 2017 to a sun-synchronous polar orbit with 97.4° inclination and an average altitude of somewhat above 500 km. RADMON has been measuring integral particle intensities from October 2017 to May 2018 with electron energies starting at low-MeV and protons from 10 MeV upwards. In this paper, we present first electron and proton intensity maps obtained over the mission period. In addition, the response of RADMON measurements to magnetospheric dynamics are analyzed, and the electron observations are compared with corresponding measurements by the PROBA-V/EPT mission. Finally, we describe the RADMON data set, which is made publicly available.</p

Aalto-1, multi-payload CubeSat: design, integration and launch

The design, integration, testing, and launch of the first Finnish satellite Aalto-1 is briefly presented in this paper. Aalto-1, a three-unit CubeSat, launched into Sun-synchronous polar orbit at an altitude of approximately 500 km, is operational since June 2017. It carries three experimental payloads: Aalto Spectral Imager (AaSI), Radiation Monitor (RADMON), and Electrostatic Plasma Brake (EPB). AaSI is a hyperspectral imager in visible and near-infrared (NIR) wavelength bands, RADMON is an energetic particle detector and EPB is a de-orbiting technology demonstration payload. The platform was designed to accommodate multiple payloads while ensuring sufficient data, power, radio, mechanical and electrical interfaces. The design strategy of platform and payload subsystems consists of in-house development and commercial subsystems. The CubeSat Assembly, Integration & Test (AIT) followed Flatsat -- Engineering-Qualification Model (EQM) -- Flight Model (FM) model philosophy for qualification and acceptance.The paper briefly describes the design approach of platform and payload subsystems, their integration and test campaigns, and spacecraft launch. The paper also describes the ground segment & services that were developed by the Aalto-1 team.</p

FORESAIL-1 cubesat mission to measure radiation belt losses and demonstrate de-orbiting

Abstract Today, the near-Earth space is facing a paradigm change as the number of new spacecraft is literally sky-rocketing. Increasing numbers of small satellites threaten the sustainable use of space, as without removal, space debris will eventually make certain critical orbits unusable. A central factor affecting small spacecraft health and leading to debris is the radiation environment, which is unpredictable due to an incomplete understanding of the near-Earth radiation environment itself and its variability driven by the solar wind and outer magnetosphere. This paper presents the FORESAIL-1 nanosatellite mission, having two scientific and one technological objectives. The first scientific objective is to measure the energy and flux of energetic particle loss to the atmosphere with a representative energy and pitch angle resolution over a wide range of magnetic local times. To pave the way to novel model - in situ data comparisons, we also show preliminary results on precipitating electron fluxes obtained with the new global hybrid-Vlasov simulation Vlasiator. The second scientific objective of the FORESAIL-1 mission is to measure energetic neutral atoms (ENAs) of solar origin. The solar ENA flux has the potential to contribute importantly to the knowledge of solar eruption energy budget estimations. The technological objective is to demonstrate a satellite de-orbiting technology, and for the first time, make an orbit manoeuvre with a propellantless nanosatellite. FORESAIL-1 will demonstrate the potential for nanosatellites to make important scientific contributions as well as promote the sustainable utilisation of space by using a cost-efficient de-orbiting technology.Peer reviewe

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed